# FDA Inspection 1021861 - Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd - July 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/shijiazhuang-lonzeal-pharmaceuticals-co-ltd/a695bc97-a489-4233-9126-af9cf83dc191
Source feed: FDA_Inspections

> FDA Inspection 1021861 for Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd on July 14, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021861
- Company Name: Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd
- Inspection Date: 2017-07-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1254673 - 2024-10-18](https://www.keypedia.com/records/fda_inspections/shijiazhuang-lonzeal-pharmaceuticals-co-ltd/a77d4e95-aee9-49f7-bd45-fc7bf950a206)
- [FDA Inspection 1254673 - 2024-10-18](https://www.keypedia.com/records/fda_inspections/shijiazhuang-lonzeal-pharmaceuticals-co-ltd/a19e56e9-4745-4b93-a919-5a5f96eab613)

Company: https://www.keypedia.com/companies/shijiazhuang-lonzeal-pharmaceuticals-co-ltd/1734ebde-7148-4f59-9298-e962fd760058

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c